Data gathered: November 27
AI Stock Analysis - Penumbra (PEN)
Analysis generated February 10, 2024. Powered by Chat GPT.
Penumbra is a global healthcare company that designs, develops, manufactures, and markets innovative medical devices. The company is specialized in products that address challenging medical conditions in markets such as neuro and peripheral vascular conditions. Penumbra's commitment to improving patient outcomes through cutting-edge technology has positioned it as a leader in its respective fields, fostering a reputation for innovation and quality.
Stock Alerts - Penumbra (PEN)
 |
Penumbra | November 26 Business Outlook among employees is down by 3.6% over the last month. |
|
Penumbra | November 23 Insider Alert: Elsesser Adam is selling shares |
|
Penumbra | November 20 Insider Alert: Roberts Johanna is selling shares |
|
Penumbra | November 5 Business Outlook among employees is up by 3.6% over the last month. |
Alternative Data for Penumbra
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 73 | Sign up | Sign up | Sign up |
| Sentiment | 94 | Sign up | Sign up | Sign up |
| Webpage traffic | 41,000 | Sign up | Sign up | Sign up |
| Employee Rating | 64 | Sign up | Sign up | Sign up |
| Google Trends | 65 | Sign up | Sign up | Sign up |
| Patents | 62 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 25 | Sign up | Sign up | Sign up |
| Facebook Followers | 1,680 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 912 | Sign up | Sign up | Sign up |
| Twitter Followers | 4,137 | Sign up | Sign up | Sign up |
| Twitter Mentions | 61 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 3,810 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 53 | Sign up | Sign up | Sign up |
| Linkedin Employees | 2,653 | Sign up | Sign up | Sign up |
About Penumbra
Penumbra, Inc., together with its subsidiairies, designs, develops, manufactures, and markets medical devices in the United States and internationally.
| Price | $244.15 |
| Target Price | Sign up |
| Volume | 199,710 |
| Market Cap | $9.39B |
| Year Range | $163.64 - $248.96 |
| Dividend Yield | 0% |
| PE Ratio | 278.05 |
| Analyst Rating | 71% buy |
| Industry | Medical Devices |
In the news
 |
FY2024 EPS Estimates for Penumbra Lifted by Leerink PartnrsNovember 26 - ETF Daily News |
|
Massachusetts Financial Services Co. MA Purchases New Shares in Penumbra, Inc. (NYSE:PEN)November 26 - ETF Daily News |
 |
Penumbra, Inc. (PEN): Innovating in Thrombectomy and Embolization with New FDA-Approved TechnologiesNovember 25 - Yahoo |
|
Intech Investment Management LLC Has $2.34 Million Stock Holdings in Penumbra, Inc. (NYSE:PEN)November 25 - ETF Daily News |
 |
Piper Sandler Forecasts Strong Price Appreciation for Penumbra (NYSE:PEN) StockNovember 24 - ETF Daily News |
 |
3 Reasons Growth Investors Will Love Penumbra (PEN)November 21 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 301M | 101M | 200M | 30M | 36M | 0.850 |
| Q2 '24 | 299M | 77M | -77M | -60M | 3.6M | 0.640 |
| Q1 '24 | 279M | 98M | 181M | 11M | 18M | 0.410 |
| Q4 '23 | 285M | 98M | 187M | 54M | 41M | 0.760 |
| Q3 '23 | 271M | 93M | 178M | 9.2M | 15M | 0.670 |
Insider Transactions View All
| Elsesser Adam filed to sell 865,443 shares at $236. November 22 '24 |
| Elsesser Adam filed to sell 852,582 shares at $238.5. November 22 '24 |
| Elsesser Adam filed to sell 855,863 shares at $237.7. November 22 '24 |
| Elsesser Adam filed to sell 860,193 shares at $236.7. November 22 '24 |
| Roberts Johanna filed to sell 64,044 shares at $241.7. November 19 '24 |
Similar companies
Read more about Penumbra (PEN) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Penumbra?
The Market Cap of Penumbra is $9.39B.
What is Penumbra's PE Ratio?
As of today, Penumbra's PE (Price to Earnings) ratio is 278.05.
What is the current stock price of Penumbra?
Currently, the price of one share of Penumbra stock is $244.15.
How can I analyze the PEN stock price chart for investment decisions?
The PEN stock price chart above provides a comprehensive visual representation of Penumbra's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Penumbra shares. Our platform offers an up-to-date PEN stock price chart, along with technical data analysis and alternative data insights.
Does PEN offer dividends to its shareholders?
As of our latest update, Penumbra (PEN) does not offer dividends to its shareholders. Investors interested in Penumbra should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Penumbra?
Some of the similar stocks of Penumbra are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.